Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus.
Zaltzman
Jeffrey S
JS
Renal Transplantation, St Michael's Hospital, University of Toronto, 30 Bond St, Toronto, Ontarion, Canada M5B1W8. jeffrey.zaltzman@utoronto.ca
Prasad
Ramesh
R
Chun
Kathy
K
Jothy
Serge
S
D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011183:Postoperative Complications; D020123:Sirolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D020123:Sirolimus